Leflunomide as a remission-maintaining therapy in difficult-to-treat dermatomyositis

Ann Rheum Dis. 2008 May;67(5):723. doi: 10.1136/ard.2007.073221.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Dermatomyositis / drug therapy*
  • Drug Therapy, Combination
  • Female
  • Follow-Up Studies
  • Humans
  • Immunosuppressive Agents / therapeutic use*
  • Isoxazoles / therapeutic use*
  • Leflunomide
  • Middle Aged
  • Prednisolone / therapeutic use

Substances

  • Immunosuppressive Agents
  • Isoxazoles
  • Prednisolone
  • Leflunomide